Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MURANO: Venetoclax + Rituximab in R/R CLL
NCT02005471Phase 3Completed
- Sponsor
- Roche
- Start
- Mar 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of venetoclax in chronic lymphocytic leukemia (CLL), sponsored by Roche. Started Mar 2014; status: completed.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT02005471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005471.